Sodium valproate Desitin oral solution is used for:
The primary form of generalized epilepsy:
typical and atypical absence seizures (petit mal)
myoclonus
tonic-clonic seizures (grand mal)
mixed forms of tonic-clonic seizures and absence seizures
May also be used for manifestations of epilepsy that do not respond adequately to other antiepileptic drugs, such as:
the secondary form of generalized epilepsy, particularly akinetic and atonic seizures
partial epilepsy, with both simple (focal) and complex (psychomotor) symptoms
Treatment of manic episodes in bipolar disorder when lithium is contraindicated or not tolerated.
Sodium valproate Desitin oral solution contains 300 mg per 5 ml. This solution is supplied in a 250 ml brown glass bottle with a cap. The pack includes a PE/PP dosing syringe for oral administration with a 5 ml capacity and 0.5 ml markings, as well as an adapter for the bottle.
Sodium valproate Desitin is a prescription-only medicine and is distributed by TwinPharma BV. Desitin Arzneimittel GmbH is the marketing authorisation holder.